RaDiCo-DCP - Primary Ciliary Dyskinesia: Identification of specific severity criteria and phenotype-genotype correlation study

Head :
MAITRE Bernard, Inserm U 955

Last update : 01/26/2024 | Version : 1 | ID : 73379

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Primary Ciliary Dyskinesia: Identification of specific severity criteria and phenotype-genotype correlation study
Sign or acronym RaDiCo-DCP
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CCTIRS n° 16.049Bis / CNIL Decision DR-2016-391 / CEEI n°15-259 bis
General Aspects
Medical area Anatomy - Cytology
Biology
Otolaryngology or ENT
Pediatrics
Pneumology
Rare diseases
Urology, andrology and nephrology
Study in connection with Covid-19 No
Pathology (details) Primary Ciliary Dyskinesias (PCD) are respiratory diseases related to a constitutional abnormality of the cilia that affects the axonema, a structure common to cilia and flagella. PCDs provok upper and lower airway infections, secondary to alterations in muco-ciliary purification, which are classically manifested in childhood. These respiratory infections result in recurrent bronchopulmonary disease and rhinosinusitis, progressing to bronchial dilation and nasal polyposis, respectively. In half of the cases, there is a reverse rotation of the viscera (situs inversus), resulting in Kartagener's syndrome, defined by the triad of bronchiectasis, chronic sinusitis and situs inversus, which therefore constitutes a subgroup of PCDs. The first and most common ciliary abnormality, found in patients with PCD, corresponds to an absence of the outer dynein arms that carry the ATPase activity essential for ciliary movement. Many other ultrastructural abnormalities of the cilia were subsequently described in the context of PCDs. Most affected men are sterile due to immobility of the flagellum of the spermatozoa, which then present the same ultrastructural defect as that of the respiratory cilia. The incidence of PCDs in the general population is estimated to be 1/16000. The transmission of PCDs is classically autosomal recessive, with the frequency of affected individuals being much higher in populations where there is a high degree of inbreeding.
Health determinants Genetic
Healthcare system and access to health care services
Occupation
Social and psychosocial factors
Scientific investigator(s) (Contact)
Name of the director MAITRE
Surname Bernard
Address Service de Pneumologie
Centre hospitalier intercommunal de Créteil
40 avenue de Verdun
94000 Créteil
FRANCE
Phone +33 (0)1 57 02 20 82
Unit Inserm U 955
Organization French National Institute for Health and Medical Research (Inserm)
Collaborations
Participation in projects, networks and consortia Yes
Details Filière Maladies Rares pulmonaires RespiFil. / European Reference Network ERN-LUNG
Funding
Funding status Public
Details Funded by the French « Investissements d’Avenir » cohorts programme, Grant « ANR » 10-COHO-0003.
Governance of the database
Sponsor(s) or organisation(s) responsible French National Institute for Health and Medical Research (Inserm)
Organisation status Public
Presence of scientific or steering committees Yes
Labelling and database evaluation Security audit certification of the database. Data management and continuous quality control of data.
Additional contact
Main features
Type of database
Type of database Morbidity registers
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Depending on their symptomatology, the initial management of patients suspected of PCD is carried out in a paediatric, ENT, adult pneumology, paediatric pneumology, or reproductive biology department that undertakes etiological explorations, in particular ciliary investigations that make it possible to confirm the diagnosis of PCD.
The RaDiCo-DCP cohort will consist of 300 prevalent and incident patients, both paediatric and adult, who will be followed for 5 years after their inclusion in the study.
Database objective
Main objective The main objective is to identify in a large cohort of PCD patients, early predictors of severity in order to improve personalized patient management.
Inclusion criteria All prevalent patients and incidents included in the RaDiCo-DCP cohort must:
• Have a confirmed diagnosis of PCD based on at least one of the following diagnostic criteria: Kartagener syndrome (association of chronic sinusitis, bronchiectasis and situs inversus), and/or evidence of specific abnormalities of the ciliary ultrastructure, and/or identification of unambiguous mutations in a PCD gene.
• Have at least one annual follow-up visit in accordance with standard practice.

Patients who meet the following criteria will not be included:
• Patient with an unconfirmed diagnosis of PCD;
• Patient with a concomitant progressive pathology that may interfere with the evaluation of PCD-related manifestations.
Population type
Age Newborns (birth to 28 days)
Infant (28 days to 2 years)
Early childhood (2 to 5 years)
Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology Q34 - Other congenital malformations of respiratory system
Gender Male
Woman
Geography area National
Detail of the geography area Complete coverage of the French territory by the Reference and Competence Centers for Rare Lung Diseases
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2017
Date of last collection (YYYY or MM/YYYY) 2028
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 300 estimated
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data Demographics; General, respiratory and ENT assessments; Fertility; Genetics; Therapeutic
Declarative data (detail) Paper self-questionnaire
Internet self-questionnaire
Face to face interview
Paraclinical data (detail) Respiratory assessment (radiological and EFR); Paraclinical ENT assessment; NO assessment and ciliary explorations
Biological data (detail) Bacteriological evaluation
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Quality of life/health perception
Quality of life/perceived health (detail) Cohort-developed, age-appropriate quality of life questionnaires and SNOT – 22 test reviewing 22 symptoms reflecting the pathological burden of patients with rhinological diseases.
Procedures
Data collection method eCRF in secure web access, secure cloud and HADS hosting
Classifications used HPO, ICD10, Snomed CT, Orpha Codes and ORDO, Drug dictionary (DCIs)
Quality procedure(s) used Data Management Plan and Data Validation Plan. Continuous data management (automatic control rules and query system)
Participant monitoring Yes
Monitoring procedures Monitoring by convocation of the participant
Monitoring by contact with the referring doctor
Monitoring by crossing with a morbidity register
Followed pathology Q34 - Other congenital malformations of respiratory system
Links to administrative sources No
Promotion and access
Promotion
Access
Presence of document that lists variables and coding procedures Yes
Terms of data access (charter for data provision, format of data, availability delay) Requests for access to RaDiCo-DCP data (aggregated or individual) will be considered by the Scientific Committee following the submission of a summary of a specific research project, as defined in the Charter of access to resources. Requests should be sent to: dcp@radico.fr
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05